Drug Shortage Report for SURVANTA
Report ID | 93565 |
Drug Identification Number | 02016109 |
Brand name | SURVANTA |
Common or Proper name | SURVANTA 8mL vial |
Company Name | ABBVIE CORPORATION |
Market Status | MARKETED |
Active Ingredient(s) | BERACTANT |
Strength(s) | 25MG |
Dosage form(s) | SUSPENSION |
Route of administration | INTRATRACHEAL |
Packaging size | 8mL vial (010401320) |
ATC code | R07AA |
ATC description | OTHER RESPIRATORY SYSTEM PRODUCTS |
Reason for shortage | Demand increase for the drug. |
Anticipated start date | 2019-09-10 |
Actual start date | 2019-09-10 |
Estimated end date | 2019-09-18 |
Actual end date | 2019-09-18 |
Shortage status | Resolved |
Updated date | 2019-09-19 |
Company comments | We are currently on managing our inventory for Survanta 8 mL due to an unexpected increase in market demand. Shall you not be in the position to wait until the predicted resolution date for your order, we do have normal inventory levels of Survanta 4 mL that can be provided instead. |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 8401 TRANS-CANADA HIGHWAY SAINT-LAURENT, QUEBEC CANADA H4S 1Z1 |
Company contact information | Should you require any additional information, please contact our Customer Service Department at 1-888-704-8270. |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v6 | 2019-09-19 | English | Compare |
v5 | 2019-09-18 | French | Compare |
v4 | 2019-09-18 | English | Compare |
v3 | 2019-09-11 | French | Compare |
v2 | 2019-09-11 | English | Compare |
v1 | 2019-09-11 | English | Compare |
Showing 1 to 6 of 6